Cryoport stock fell 1.87 percent near its 52-week high

Published on 10/07/2026 at 00:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cryoport stock closed at USD 17.80 on October 6, 2026, while its average analyst target was USD 18.38. Q2 revenue reached USD 48.97 million versus USD 48.18 million consensus.

CYRX, US2290503075, Illustration mit AI erstellt.

Cryoport stock (ISIN US2290503075) closed at USD 17.80 on Nasdaq on October 6, 2026, down 1.87 percent from the prior close of USD 18.14. The session also produced a 52-week high of USD 18.36, putting the stock near the upper end of its USD 7.61 to USD 18.36 annual range.

Revenue beat but losses persisted

For the quarter ended June 30, 2026, Cryoport reported revenue of USD 48.97 million and a diluted EPS loss of USD 0.20. According to Cryoport, the second-quarter release was published on August 6, 2026.

The revenue figure exceeded the USD 48.18 million consensus estimate, while the EPS loss was wider than the USD 0.19 consensus loss. That split matters for investors because top-line demand was ahead of expectations even as profitability remained the central constraint.

Analysts see limited upside

MarketBeat lists a Moderate Buy consensus based on 9 analyst ratings, including 7 Buy, 1 Hold and 1 Sell rating. The average 12-month target is USD 18.38, with a high of USD 25.00 and a low of USD 12.50.

At the October 6 closing price, the average target lies 3.26 percent above the stock price. The narrow gap contrasts with the wider target range, showing that analyst conviction is positive overall but dispersed across a broad valuation spectrum.

Guggenheim raises its target

Guggenheim raised its Cryoport target to USD 19.00 from USD 16.00 and maintained a Buy rating on October 1, 2026, according to Markets Insider. The firm cited updated models and forecasts ahead of the sector earnings season.

Cryoport's business centers on temperature-controlled logistics, storage and related services for cell and gene therapies, biologics, vaccines and reproductive materials. The operating profile gives revenue growth strategic importance, but the latest quarterly EPS loss shows that sales expansion has not yet translated into net profitability.

Stock remains near yearly high

Cryoport closed at USD 17.80 on Nasdaq on October 6, 2026, with volume of 841,765 shares and a market capitalization of USD 897.2 million. The next valuation checkpoint is whether quarterly revenue progress can narrow the gap between the company's growth profile and its continuing losses.